Cite Filings / KOD / 0000902664-26-001849
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G

Statement of Beneficial Ownership

Kodiak Sciences Inc. · Filed 2026-04-02 · Acc 0000902664-26-001849

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-04-27 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-04-02 144 Sale of Securities
  • 2026-04-02 4 Chief Financial Officer sold 30,000 shares at an average $39.92 ($1,197,488)
  • 2026-04-02 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-03-31 S-8 Securities Offered to Employees in Benefit Plans
  • 2026-03-31 10-K Annual Report
  • 2025-08-19 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Sirenia Capital Management LP 2.9%
  2. 2026-11-16 SCHEDULE 13G/A · T. Rowe Price Associates, Inc. 4.7%
  3. 2026-09-30 SCHEDULE 13D/A · Baker Bros. Advisors LP 35.0%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…